Molecular Pharmacology within the realm of Biopharmaceutics explores the intricate interactions between drugs and biological entities at the molecular level. This field delves into the mechanisms by which pharmaceutical agents exert their effects, emphasizing the understanding of molecular pathways, receptor binding, and signaling cascades.
In the context of Biopharmaceutics, Molecular Pharmacology plays a pivotal role in deciphering how drugs interact with biological systems, influencing pharmacokinetics and pharmacodynamics. This knowledge is crucial for optimizing drug formulations, enhancing therapeutic efficacy, and minimizing adverse effects.
Researchers in Molecular Pharmacology within Biopharmaceutics utilize advanced techniques to study drug-receptor interactions, cellular responses, and the impact of genetic variations on drug metabolism. This interdisciplinary approach fosters the development of precision medicine and personalized drug therapies, ushering in a new era of targeted and efficient pharmaceutical interventions.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia